Nia Therapeutics unveils first implantable brain interface for memory disorders
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
The Toumai platform, currently the only robotic system with US FDA Study Approval for telesurgery, enabled real-time surgical control with no compromise to patient safety
Her journey includes leading HR for large and diverse teams across sales, marketing, corporate functions, and R&D
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Indian companies must make their own intermediates and support small industries: Dr. K. Nagaiah, Chief Scientist, CSIR - IICT, Hyderabad
New funding to advance non-surgical brain interface technology and expand clinical and engineering capabilities globally
Syngene International has reported total income of Rs. 926 crore during the period ended September 30, 2025
Bioconjugation capability to complement commercial payload, linker, and monoclonal antibody services
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
Subscribe To Our Newsletter & Stay Updated